Three independent discounted-cash-flow-style models value Surgery Partners, Inc. Common Stock every trading day. 2 of 3 currently price SGRY above its market price.
| Free Cash Flow model | $288.94 |
| Excess Profit model | $237.67 |
| Residual Earnings model | $0.08 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +5.6% |
| Net debt / EBITDA | 9.0× |
| Gross margin | +100.0% |
| Revenue CAGR | +9.2% |
| Cash conversion | 2.8× |
| Dividend yield | — |
| Buyback yield | -0.9% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open SGRY in StockKitty